Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 2/20 | 0.53 |
| ▸ | UMPS | P11172 | 1/20 | 0.47 |
| ▸ | IMPDH2 | P12268 | 14/20 | 0.45 |
| ▸ | IMPDH1 | P20839 | 10/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiazofurin SCHEMBL1651851 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL7169632 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL4453888 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL23848843 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL2883659 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL23264566 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL13109276 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| Tiazofurin SCHEMBL2883657 | 1.00 | PYGL (0.53) | PYGLUMPSIMPDH2IMPDH1 | |
| SCHEMBL7832887 | 0.89 | PYGL (0.53) | PYGLUMPS | |
| SCHEMBL23375983 | 0.88 | PYGL (0.43) | PYGLIMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17571 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103922-A1 | CHIMERIC SHUTTLING RECEPTOR | 深圳市湾岛细胞科技有限公司 | 2026-05-21 | — | — | WO | claimed |
| CN-122060073-A | Chimeric shuttle receptors | 深圳市湾岛细胞科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026086785-A1 | EUKARYOTIC CELLS EXPRESSING EXOGENOUS INOSINE MONOPHOSPHATE DEHYDROGENASE COMPRISING CHIMERIC ANTIGEN RECEPTOR BINDING TO GUCY2C | SHENZHEN WONDERCEL BIOTECHNOLOGY LIMITED (CN) | 2026-04-30 | — | — | WO | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3515892-B1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4696718-A2 | TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY | Novartis AG (CH) | 2026-02-18 | — | — | EP | claimed |
| US-20260028400-A1 | ANTI-ROR1 ANTIBODY AND USE THEREOF | AIMED BIO INC (KR) | 2026-01-29 | — | — | US | claimed |
| EP-0224283-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-06-03 | — | — | EP | claimed |
| EP-0222425-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-20 | — | — | EP | claimed |
| EP-0221588-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-13 | — | — | EP | claimed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| US-4451648-A | VIRICIDE BY MULTI-STEP PROCESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-05-29 | — | — | US | claimed |
| US-4446315-A | ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-05-01 | — | — | US | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| EP-0072977-A1 | Process for the production of 2-beta-D-ribofuranosylthiazole-4-carboxamide | Starks Associates, Incorporated (US) | 1983-03-02 | — | — | EP | claimed |
| EP-0054432-A1 | Use of 2-Beta-D-ribofuranosylthiazole-4-carboxamides for the manufacture of medicaments inhibiting malignant tumors | VIRATEK, INC. (US) | 1982-06-23 | — | — | EP | claimed |